Iluvien receives marketing authorization in Sweden for chronic diabetic macular edema Sep. 4, 2014 No Comments
Amarantus gains rights to MANF for retinal diseases from University of Miami Aug. 19, 2014 No Comments
Ablynx awarded grant supporting nanobody development for ocular applications Aug. 18, 2014 No Comments
RSS